Reference

    Glossary

    Plain-language definitions for science, product, health and policy terms.

    Cannabinoid
    A biologically active compound that interacts with cannabinoid receptors in the body. THC and CBD are the best-known cannabinoids.
    THC (Delta-9 THC)
    The primary intoxicating compound in cannabis. Responsible for the 'high' and many of the psychoactive effects.
    CBD (Cannabidiol)
    A non-intoxicating cannabinoid. Biologically active and can interact with medications; retail products differ from prescription medicines.
    THCA
    The acidic, non-intoxicating form of THC found in raw cannabis. Converts partly to THC when heated.
    CBDA
    The acidic precursor to CBD found in raw cannabis plants.
    Endocannabinoid system (ECS)
    A biological system of receptors, signaling molecules and enzymes involved in processes including pain, appetite, memory and stress response.
    CB1 receptor
    Cannabinoid receptor found primarily in the central nervous system. Strongly involved in the intoxicating effects of THC.
    CB2 receptor
    Cannabinoid receptor found in immune and peripheral tissues. Less involved in intoxication than CB1.
    Certificate of Analysis (CoA)
    A laboratory report documenting batch identity, cannabinoid potency, terpene profile and contaminant testing results for a cannabis product.
    Terpene
    Aromatic compounds found in cannabis and many other plants. Terpenes affect aroma but consumer health claims are not established by strong clinical evidence.
    Onset
    The time it takes for cannabis effects to begin after consumption. Varies significantly by route of administration.
    Route of administration
    How cannabis enters the body. Common routes include inhalation (smoking, vaping), oral (edibles, beverages) and sublingual (under the tongue).
    Sublingual
    Absorbed under the tongue. Tinctures held under the tongue may act faster than swallowed products, but timing varies.
    Edible
    A food or beverage product containing cannabis. Slower onset than inhaled forms, longer duration, and higher risk of overconsumption.
    Cannabis use disorder
    A clinical condition in which continued cannabis use causes meaningful problems or becomes difficult to control.
    Tolerance
    A reduced response to a substance over time, often requiring more to achieve the same effect.
    Dependence
    A state in which the body adapts to a substance and withdrawal symptoms occur when it is stopped.
    Contaminant testing
    Laboratory analysis for microbes, mold, pesticides, heavy metals and residual solvents in cannabis products.
    Potency
    The concentration or strength of a cannabinoid, often expressed as a percentage or milligrams.
    Harm reduction
    Public-health strategies that aim to reduce harms from substance use without necessarily requiring abstinence.
    Schedule I
    The federal drug classification for cannabis under the Controlled Substances Act, indicating no accepted medical use and high potential for abuse under federal law.
    Impairment
    A reduction in the ability to think, react, coordinate or make decisions safely. Cannabis can cause impairment even when a person feels subjectively normal.
    Lower-risk use guidelines
    Evidence-based recommendations, such as Health Canada's Lower-Risk Cannabis Use Guidelines, that identify behaviors associated with reduced cannabis-related harms.